Book Building
₹ 408.79 cr
₹ 392
38
₹ 14,896.00
MumbaiNSE
24-Mar-2026
27-Mar-2026
02-Apr-2026
The Shares of Sai Parenteral's Ltd have now been listed.
Initial public offer of 10,428,288 equity shares of face value of Rs. 5 each (Equity Shares) of Sai Parenteral's Limited (Company or Issuer) for cash at a price of Rs. 392 per equity share (Including a Share Premium of Rs. 387 Per Equity Share) (Offer Price) aggregating to Rs. 408.79 Crore comprising a fresh issue of 7,270,408 equity shares of face value of Rs. 5 each aggregating to Rs. 285 Crore by the company (Fresh Issue) and an offer for sale of 3,157,880 equity shares of face value of Rs. 5 each aggregating to Rs. 123.79 Crore (Offered Shares) by investor selling shareholders (such sale, the Offer For Sale, and together with the fresh issue, theOffer). The offer shall constitute 23.60% of the post-offer paid up equity share capital of the company.Price Band: Rs. 392 per equity share of face value of Rs. 5 each.The floor price is 78.40 times the face value of the equity shares. Bids can be made for a minimum of 38 equity shares of face value of Rs. 5 each and in multiples of 38 equity shares of face value of Rs. 5 each thereafter.
Capacity expansion and upgradation of manufacturing facilities. Establishment of a new R&D Centre. Repayment / prepayment of certain outstanding borrowings. Working capital requirements. Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia). General corporate purposes.
Sai Parenteral's Ltd, Office No S6-2, Pinnacle Busine.Park, Mahakali Caves Road, Mumbai - 400093
Phone - 91-22-62638200
Fax - 91-22-63638299
Email - cs@saiparenterals.com
Website - https:, www.saiparenterals.com